What's new

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 22, Status: Authorised

Feb 9, 2025 - 22:26
 0
Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 22, Status: Authorised
Read More

Tags:

Previous Article

Eldisine

Next Article

Non-clinical Working Party

Related Posts

3Rs Working Party

3Rs Working Party

Feb 9, 2025  0

Procurement

Procurement

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Leqembi, Lecanemab, Status: Opinion

Human medicines European public assessment report (EPAR...

Feb 28, 2025  0